Bank of America’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Sell |
127,371
-109,376
| -46% | -$1.75M | ﹤0.01% | 3993 |
|
|
2025
Q1 | $3.6M | Buy |
236,747
+166,010
| +235% | +$2.53M | ﹤0.01% | 3492 |
|
|
2024
Q4 | $1.43M | Buy |
70,737
+33,028
| +88% | +$670K | ﹤0.01% | 3992 |
|
|
2024
Q3 | $969K | Sell |
37,709
-24,302
| -39% | -$625K | ﹤0.01% | 4301 |
|
|
2024
Q2 | $797K | Buy |
62,011
+54,176
| +691% | +$697K | ﹤0.01% | 4304 |
|
|
2024
Q1 | $179K | Sell |
7,835
-16,176
| -67% | -$370K | ﹤0.01% | 5099 |
|
|
2023
Q4 | $629K | Buy |
24,011
+22,954
| +2,172% | +$601K | ﹤0.01% | 4462 |
|
|
2023
Q3 | $29.7K | Sell |
1,057
-639
| -38% | -$18K | ﹤0.01% | 5731 |
|
|
2023
Q2 | $51.5K | Sell |
1,696
-940
| -36% | -$28.6K | ﹤0.01% | 5595 |
|
|
2023
Q1 | $49.6K | Buy |
2,636
+591
| +29% | +$11.1K | ﹤0.01% | 5708 |
|
|
2022
Q4 | $20.9K | Buy |
2,045
+247
| +14% | +$2.52K | ﹤0.01% | 5928 |
|
|
2022
Q3 | $47K | Buy |
1,798
+629
| +54% | +$16.4K | ﹤0.01% | 5860 |
|
|
2022
Q2 | $53K | Buy |
1,169
+55
| +5% | +$2.49K | ﹤0.01% | 6012 |
|
|
2022
Q1 | $110K | Sell |
1,114
-1,616
| -59% | -$160K | ﹤0.01% | 6031 |
|
|
2021
Q4 | $417K | Buy |
2,730
+645
| +31% | +$98.5K | ﹤0.01% | 5245 |
|
|
2021
Q3 | $283K | Buy |
2,085
+1,680
| +415% | +$228K | ﹤0.01% | 5228 |
|
|
2021
Q2 | $59K | Buy |
+405
| New | +$59K | ﹤0.01% | 5953 |
|